SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-09-002908
Filing Date
2009-04-17
Accepted
2009-04-17 17:01:21
Documents
5
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 BIOGEN IDEC INC. b75004bie10vq.htm 10-Q 935217
2 EX-10.1 AMENDMENT NO.1 TO CREDIT AGREEMENT b75004biexv10w1.htm EX-10.1 25401
3 EX-31.1 SECTION 302 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER b75004biexv31w1.htm EX-31.1 8389
4 EX-31.2 SECTION 302 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER b75004biexv31w2.htm EX-31.2 8402
5 EX-32.1 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 b75004biexv32w1.htm EX-32.1 4558
  Complete submission text file 0000950135-09-002908.txt   983562
Mailing Address 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142 6176792000
BIOGEN IDEC INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19311 | Film No.: 09757425
SIC: 2836 Biological Products, (No Diagnostic Substances)